Comparing the Diagnostic Value of the Risk of Ovarian Malignancy Algorithm and CA125 in Patients with Ovarian Mass
Background and purpose: Ovarian cancer is the fourth leading cause of death from gynecological cancers in women. Using specific tumor markers that help in making diagnosis at early stages improve therapeutic outcomes. The purpose of this study was to evaluate the diagnostic value of the Risk of Ovar...
Main Authors: | Alireza Rezaee, leila Pourali, Ramin Mashoofi, somayeh Moeen darbari, Samaneh Shoghi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2019-07-01
|
Series: | Journal of Mazandaran University of Medical Sciences |
Subjects: | |
Online Access: | http://jmums.mazums.ac.ir/article-1-12316-en.html |
Similar Items
-
Is Ovarian Mass Malignancy Prediction Accuracy Increased by Adding Serum CA125 Measurement to Sonographic Findings?
by: Maliheh Arab, et al.
Published: (2012-03-01) -
Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian Cancer
by: Khawla Al-Musalhi, et al.
Published: (2015-11-01) -
Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
by: Juan Fernando Sánchez Vega, et al.
Published: (2018-05-01) -
CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01) -
Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative
by: Charles J. Dunton, et al.
Published: (2021-08-01)